Avidity Biosciences Inc. Skyrocketed
Wed, Jun 12, 2024 at 07:30 PM
Avidity Biosciences Inc. (RNA:NASDAQ) soared at $38.36, representing a gain of 32.6%. On Wed, Jun 12, 2024, RNA:NASDAQ touched a New 2-Week High of $38.36. The stock got featured on our News Catalysts scanner on Wed, Jun 12, 2024 at 06:57 PM in the 'PUBLIC OFFERING' category. From Wed, May 29, 2024, the stock recorded 80.00% Up Days and 63.64% Green Days
About Avidity Biosciences Inc. (RNA:NASDAQ)
Avidity Biosciences Inc is a bio-technology company.
Top 10 Gainers:
- NYSE Tick Pilot Test Sym-Contro (NTEST:NYSE), 867.6%
- DDC Enterprise Limited Class A (DDC:NYSEMKT), 198.1%
- Longeveron Inc. (LGVN:NASDAQ), 120.73%
- Direct Digital Holdings Inc. (DRCT:NASDAQ), 63.17%
- Unico American Corporation (UNAM:NASDAQ), 50%
- JIADE LIMITED (JDZG:NASDAQ), 38.83%
- Translate Bio, Inc. (TBIO:NASDAQ), 37.78%
- Mediaco Holding Inc. (MDIA:NASDAQ), 37.11%
- Avidity Biosciences Inc. (RNA:NASDAQ), 32.64%
- Linkage Global Inc (LGCB:NASDAQ), 31.11%